Cardiology Online - International Academy of Cardiology
 
»search site
The International Academy of Cardiology is dedicated to the advancement of global research in cardiovascular medicine through the support of scientific meetings and publications.
   Home Page
   Congresses
   Journals
   Organizations
   Institutions
   Books
   Research
   Guidelines
   Discussion Groups
   Webcourses
   Websites
   Job Opportunities
   Contact Us




 

 

 

 


18th World Congress on Heart Disease

 

MACROPHAGES TRANSMIT POTENT PROANGIOGENIC EFFECTS OF oxLDL IN VITRO AND IN VIVO INVOLVING HIF-1a ACTIVATION: A NOVEL ASPECT OF ANGIOGENESIS IN ATHEROSCLEROSIS


Randolph Hutter, M.D., The Cardiovascular Institute, Mount Sinai School of Medicine, New York, NY, USA

 

Background: Neovascularization has been linked to the progression and vulnerability of atherosclerotic lesions. Angiogenesis is increased in lipid-rich plaque. Hypoxia-inducible factor alpha (HIF-1a) is a key transcriptional regulator responding to hypoxia and activating genes, which promote angiogenesis, among them vascular endothelial growth factor (VEGF). Oxidized low-density lipoprotein (oxLDL) is generated in lipid-rich plaque by oxidative stress. It triggers an inflammatory response and was traditionally thought to inhibit endothelial cells. New data, however, suggest that oxLDL can activate HIF-1a in monocytes in a hypoxia-independent fashion. We hypothesized that HIF-1a activation in monocyte–macrophages could transmit proangiogenic effects of oxLDL linking hyperlipidemia, inflammation, and angiogenesis in atherosclerosis.

Methods and Results: First, we examined the effect of oxLDL on HIF-1a and VEGF expression in monocyte–macrophages and on their proangiogenic effect on endothelial cells in vitro in a monocyte–macrophage/endothelial co-culture model. OxLDL strongly induced HIF-1a and VEGF in monocyte–macrophages (23±5 vs. 0.0±0 %; P<0.05) and VEGF (37±6 vs. 4±2 %; P<0.05) compared to untreated controls under normoxic conditions and significantly increased tube formation in co-cultured endothelial cells. HIF-1a inhibition with chetomin reversed this effect. Second, we demonstrated a direct proangiogenic effect of oxLDL in the in vivo matrigel plug angiogenesis assay (29±4 mm of blood vessels per high power field compared to 1±0.5 mm in growth factor-depleted matrigel alone, p<0.05). Again, HIF-1a inhibition with chetomin abrogated the proangiogenic effect of oxLDL (6±1mm vs. 29±4mm; p<0.05). Third, in a rabbit atherosclerosis model, we studied the effect of dietary lipid lowering on arterial HIF-1a and VEGF expression. The administration of low-lipid diet significantly reduced the expression of both HIF-1a and VEGF, resulting in decreased plaque neovascularization. Conclusions: Our data point to oxLDL as a proangiogenic agent linking hyperlipidemia, inflammation, and angiogenesis in atherosclerosis. This effect is dependent on macrophages and, at least in part, on the induction of the HIF-1a pathway.

 

 

©1998-2014 Cardiology Online, Inc. All rights reserved.
Cardiology Online is a registered trademark of Cardiology Online, Inc.
CardiologyOnline.com